Signal active
Organization
Contact Information
Overview
Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.
About
Biotechnology, Artificial Intelligence (AI), Health Care, Medical, Health Diagnostics
2020
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Elephas headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $21.4B in funding across 120 round(s). With a team of 51-100 employees, Elephas is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Elephas, raised $55.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
6
7
0
$178.5M
Details
6
Elephas has raised a total of $178.5M in funding over 6 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 6.0M | ||
2022 | Early Stage Venture | 41.5M | ||
2023 | Late Stage Venture | 55.0M | ||
2024 | Late Stage Venture | 55.0M |
Investors
Elephas is funded by 23 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
State of Wisconsin Investment Board | - | FUNDING ROUND - State of Wisconsin Investment Board | 55.0M |
TAO Investments | - | FUNDING ROUND - TAO Investments | 55.0M |
Elephas | - | FUNDING ROUND - Elephas | 55.0M |
WARF Ventures | - | FUNDING ROUND - WARF Ventures | 55.0M |
Recent Activity
There is no recent news or activity for this profile.